Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-05-06
2008-05-06
Jiang, S. Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S081000, C514S261100, C536S026700, C536S026710, C536S027130, C544S264000
Reexamination Certificate
active
09526348
ABSTRACT:
Methods and compounds for inhibiting the enzymes adenosine monophosphate deaminase or adenoside deaminase are provided. Such methods and compounds are useful in agriculture, horticulture and/or pharmacology as, for example, active compounds for crop protection or pharmaceuticals for humans or animals.
REFERENCES:
patent: 5045557 (1991-09-01), Buss et al.
patent: 5096915 (1992-03-01), Parsons et al.
patent: 5786165 (1998-07-01), Dancer et al.
patent: WO 94/18200 (1994-09-01), None
Duffy et al., “The Scope and Mechanism of a Novel Synthesis of 3,4-Fused Isothiazoles,”Journal of the Chemical Society, Chemical Communications, 1995, (Issue No. 23), 2457-2459 (Dec. 7, 1995).
Frieden et al., “Adenosine Deaminase and Adenylate Deaminase: Comparative Kinetic Studies with Transition State and Ground State Analogue Inhibitors,”Biochemistry, 19(23), 5303-5309 (Nov. 11, 1980).
Gewald et al. (I), “New Synthesis of 4-aminoisothiazoles,”Zeitschrift für Chemie, 15(1), 18-19 (1975);Chemical Abstracts.82(21), p. 616, Abstract No. 139991k (May 26, 1975); only Abstract supplied.
Gewald et al. (II), “Synthesis and Reactions of 4-aminoisothiazoles,”Justus Liebigs Annalen der Chemie, 1979(10), 1534-1546 (Oct. 1979);Chemical Abstracts, 92(9), p. 667, Abstract No. 76382w (Mar. 3, 1980).
Kobe et al., “Use of Distance Geometry Approach for the in vitro Antiviral Activity Evaluation of N-Bridgehead C-Nucleosides,”European Journal of Medicinal Chemistry,27(3), 259-266 (1992).
Kurasawa et al., “Synthesis and Conversions of 3-(4-Amino-5-methyl-4H-1,2,4-triazol-3-ylmethylene-2-oxo-1,2,3,4-tetrahydroquinozaline,”Journal of Heterocyclic Chemistry,22(6). 1715-1718 (Nov.-Dec. 1985).
Poreba et al., “Synthesis and Preliminary Pharmacological Assessment of the Derivatives of Isoxazolo[4,3-d]pyrimidine. II,”Acta Polonica Pharm., 51(4-5), 355-358 (1994);Chemical Abstracts, 123(11), p. 1264, Abstract No. 143787f (Sep. 11, 1995); only Abstract supplied.
Poreba et al. (I), “Synthesis and Preliminary Pharmacological Assessment of the Derivatives of Isoxazolo[4,3-d]pyrimidine. II,”Acta Polonica Pharm.- Drug Research, 51(4-5), 355-358 (1994) @@;Chemical Abstracts, 123(11), p. 1264, Abstr. No. 143787f (Sep. 11, 1995).
Milne et al., “Pyrazolopyrimidine Nucleosides. Part IV. Synthesis and Chemical Reactivity of the C-Nucleoside Selenoformycin B and Derivatives,”Journal Chemical Society, Perkin Tranaactions I, 1972, pp. 2677-2681.
Watanabe et al., “The Studies on the Chemical Derivations of Formycin and Formycin B,”The Journal of Antibiotics, Series A, 19(2), 93-96 (Mar. 1966).
Long et al., “Pyrazolopyrimidine Nucleosides. Part II. 7-Substituted 3-β-D-Ribofuranosyl[3,4-d]pyrimidines Related to and Derived from the Nucleoside Antibiotics Formycin and Formycin B,”Journal of the Chemical Society(C), 1971, pp. 2443-2446.
Ramasamy et al., “Synthesis and Antitumor Activity of Certain 3-β-D-Ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines Related to Formycin Prepared via ring Closure of a 1,2,4-Triazine Precursor,”Journal of Medicinal Chemistry, 29(11), 2231-2235 (1986).
Fox et al., “Thiation of Nucleosides. I. Synthesis of 2-Amino-6-mercapto-9-β-D-ribofuranosylpurine (“Thioguanosine”) and Related Purine Nucleosides,”Journal of the Amer. Chem. Soc., 80(4), 1669-1675 (Apr. 5, 1958).
Woods et al. “Solvolytic Reactivities of Some 7-Chloronorbornane Derivatives,”Journal of the Amer. Chem. Soc., 78, 5653-5657 (Nov. 5, 1956).
Kawana et al., “Synthesis of 2-Fluoro-9-β-D-Ribofuranosylpurine (2-Fluoronebularine),”Journal of Medicinal Chemistry, 15(2), 214-215 (1972).
Nair et al., “Reductive Deamination of Aminopurine Nucleosides,”Synthesis,1984, pp. 401-404 (May 1984).
Buck et al., “Conversion of Guanosine into Acyclovir and its 6-Deoxy Derivative,”Tetrahedron,50(30), 9195-9206 (1994).
L'abbé et al., “5-Chloropyrazole-4-carboxaldehydes as Synthons for Intramolecular 1,3-Dipolar Cycloadditions,”Journal of the Chem. Soc., Perkin Transactions I, 1994, pp. 2553-2558.
Buchanan et al., “C-Nucleoside Studies. Part 19. The Synthesis of the β-D-Xylofuranosyl Analogues for Formycin,”Journal of the Chem. Soc., Perkin Transactions I, 1986, pp. 1267-1271.
Lewis et al., “Pyrazolopyrimidine Nucleosides. 13. Synthesis of the Novel C-Nucleoside 5-Amino-3-(β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidin-7-one, a Guanosine Analogue Related to the Nucleoside Antibiotic Formycin B,”Journal of the Amer. Chem. Soc., 104(4), 1073-1077 (1982).
Hennen et al., “Synthesis of 4-Substituted 5-Amino-2-(β-D-ribofuranosyl)thiazoles and 4-Substituted 5-Amino-2(β-D-ribofuranosyl)selenazoles and Their Respective Conversion into 2-(β-D-ribofuranosyl)thiazolo[5,4-d]pyrimidines and 2-(β-D-ribofuranosyl)selenazolo[5,4-d]pyrimidines. A New Synthesis of Tiazofurin and Selenazofurin,”Journal of Organic Chemistry, 50, 1741-1746 (1985).
Ivanovics et al., “The Synthesis of 2-Substituted Derivatives of 5-Amino-1-β-D-ribofuranosylimidazole-4-carboxamide. Ring Opening Reactions of 2-Azapurine Nucleosides,”Journal of Organic Chemistry, 39(25), 3651-3654 (1974).
Rayner et al., “Rechereche sur la Nucleosides de Synthese: II Obtention d'Anomeres-α en Series Purinique (French),”Heterocyclic C hemistry, 10, 417-418 (Jun. 1973).
Ellames et al., “The Synthesis of Acycloformycins and 5-Amino-3-(2-hydroxyethoxy)-methylpyrazolo[4,3-d]pyrimidin-7(6H)-one, an Analogue of the Antiviral Acycloguanosine,”Journal of the Chem. Soc., Perkin Transactions I, 1985, pp. 2087-2091.
Wierzchowski et al., “Analogues of Formycins A and B: Synthesis and Some Properties of Methyl Derivatives of 7-amino and 7-Keto Pyrazolo[4,3-d]pyrimidines,”Acta Biochimica Polonica, 27(1), 35-56 (1980).
Kalvoda, “The Synthesis of Pyrazoles: A Simple Preparative Synthesis of C-Nucleosidic Antibiotics Formycin and Formycin B,”Coll. Czech. Chem. Communications, 43, 1431-1437 (1978).
Sims et al., “Elevated Adenosine Monophosphate Deaminase Activity in Alzheimer's Disease Brain,”Neurobiology of Aging, 19(5), 385-391 (1998).
Poreba et al. (II), “Synthersis and Pharmacological Screening of Derivatives of Isoxazolo[4,3-d]pyrimidine. I,”Il Farmaco, 49(7,8), 529-532 (1994).
El-Maaty et al. (I), “Synthesis of Certain Isothiazolo[4,3-d]pyrimidine Derivatives of Pharmaceutical Interest,”Bull. Fac. Pharm. Cairo Univ., 29(2), 41-47 (1991).
El-Maaty et al. (II), “Synthesis of Certain Isothiazolo[4,3-d]pyrimidine-5,7-(4H,6H)-diones of Pharmaceutical Interest,”Egypt. J. Pharm. Sci., 34(4-6), 421-430 (1993).
Bhattacharya et al., “Synthesis of Certain N- and C-Alkyl Purine Analogs,”Journal of Heterocyclic Chemistry, 30, 1341-1349 (Oct.-Nov. 1993).
Rao et al., “Synthesis of Certain Acyclic Nucleoside Analogs of 1,2,4-Triazolo[3,4-f][1,2,4]triazine and Pyrimido[5,4-d]pyrimidine,”Nucleosides&Nucleotides, 14(7), 1601-1612 (1995).
Shaban, “The Chemistry of C-Nucleosides and Their Analogs II: C-Nucleosides of Condensed Heterocyclic Bases,”Advances in Heterocyclic Chemistry, 70, 163-309 (1996); only pp. 163-177 supplied.
Erion et al., “Discovery of AMP Mimetics that Exhibit High Inhibitory Potency and Specificity for AMP Deaminase,”Journal of the Amer. Chem. Soc., 121(2), 308-319 (1999); WEB published on Dec. 31, 1998.
Dancer et al. (II), “Adenosine-5′-Phosphate Deaminase,”Plant Physiology, 114, 119-129 (1997).
Dudfield et al, J. Chem. Soc. Perkin Trans. I (20), (1999), pp. 2937-2942, also referred to as XP 000916905.
Dudfield et al, J. Chem. Soc. Perkin Trans. I (20), (1999), pp. 2929-2936, also referred to as XP 000916904.
Lindell et al, Bioorganic & Medicinal Chemistry L
Bojack Guido
Dudfield Philip
Earnshaw Christopher G.
Lindell Stephen
Rosinger Christopher
Bayer CropScience AG
Crane L. E.
Jiang S. Anna
LandOfFree
Bicyclic heterocycles, processes for their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heterocycles, processes for their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocycles, processes for their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3932601